Loading…
Based on limited metadata available, New Life International received an FDA Warning Letter on July 21, 2020, regarding animal and veterinary products. While the specific violations cannot be detailed without access to the full letter text, the warning indicates regulatory concerns within the veterinary product category under FDA oversight. The lack of a documented subject line in this metadata limits clarity on the exact nature of the compliance issues, though they likely pertain to manufacturing, labeling, or quality control standards for animal health products.